GGrantIndex
← Search

PHASE II STUDY OF THE ACTIVITY AND SAFETY OF AUTOLOGUS CD4-ZETA GENE-MODIFIED

$207,266M01FY2000RRNIH

University Of California Los Angeles, Los Angeles CA

Investigators

Linked publications & trials

View original record on NIH RePORTER →